Arrowstreet Capital
OYST

Arrowstreet Capital’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Arrowstreet Capital’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,317
Closed -$260K – 2609
2020
Q3 		$260K Sell
12,317
-600
-5% -$14K ﹤0.01% 2161
2020
Q2 		$373K Buy
+12,917
New +$389K ﹤0.01% 2047

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Arrowstreet Capital's OYST Position: Q4 2020 in Review

Arrowstreet Capital sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2020, closing a stake of 12,317 shares — an estimated $260K sold.

Arrowstreet Capital first reported a position in OYST in Q2 2020 and held it in 2 quarters. The position peaked at $373K in Q2 2020. 60 funds tracked by Wall St. Rank hold OYST as of Q4 2020.

  • Arrowstreet Capital reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 12,317 Oyster Point Pharma, Inc. Common Stock shares in Q4 2020, an estimated $260K.
  • Arrowstreet Capital first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Arrowstreet Capital's Oyster Point Pharma, Inc. Common Stock position peaked at $373K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.